FDA Commissioner Marty Makary (Drew Angerer/AFP via Getty Images)
June 10, 2025 02:46 PM EDT
R&D
Pharma
FDA+

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

Max Bayer

Pharma Reporter

Zachary Brennan

Senior Editor

FDA Com­mis­sion­er Mar­ty Makary said he wasn’t in­volved in HHS Sec­re­tary Robert F. Kennedy Jr.’s de­ci­sion to fire every mem­ber of a key CDC ex­pert …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Ex­clu­sive: Organoid start­up rais­es $21M to test drugs and vac­cines in hu­man lymph nodes-in-a-dish

Ca­balet­ta Bio shares CAR-T re­sults in three au­toim­mune con­di­tions

Up­dat­ed: No­vo makes an­oth­er car­diometa­bol­ic deal fo­cused on oral med­i­cines

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times